HAMILTON THOMAS EDWARD purchased 7.5% of their position (50K shares) of LARIMAR THERAPEUTICS, INC. on the open market
Open‑market purchase worth $166.9K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/8/2026ACC: 0001193125-26-298523
Director
Since May 2020
+50K
Net shares
Net buyer
$166.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$3.34
Trade value
$166.89K
% of position
7.5%
7/6/2026
664.80K→714.80K
Total
Net shares
+50K
Net value
$166.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | P · Purchase | +50K | $3.34 | $166.89K | 7.5% | 664.80K | 714.80K |
| Total | +50K | $166.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned159.43K
Total
159.43K indirect159.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 159.43K | Indirect |
| Total | 159.43K | 159.43K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported